title: [Effects of As2O3 in combination with TPA on K562 cells].
abstract: This study was aimed to investigate the effects of arsenic trioxide (As2O3) combined with TPA on cell cycle, cell differentiation and apoptosis of K562 cell line, and their possible mechanisms. K562 cells were treated with 200 nmol/L TPA, 2 µmol/L As2O3 alone and 200 nmol/L TPA combined with 2 µmol/L As2O3. The proliferative inhibition rates were determined with CCK-8. Annexin V and agarose gel electrophoresis were adopted to detect apoptosis. Colony formation test was used to determine the colony-formation efficiency. Flow cytometry was used to detect the cell differentiation and cell cycle changes. Western blot was employed to detect the expression of P38 and p-P38 proteins. The results showed that combination treatment had synergistic effects on the proliferative inhibition and apoptosis, which were much higher than those treated alone. As2O3 could decrease the colony formation ability of K562 cells. The cells treated with both TPA and As2O3 expressed far more CD11b antigens compared with cells exposed to As2O3 alone. K562 cells treated with TPA were arrested in G1 phase compared with the control group, As2O3 increased the percentage of K562 cells in the G2 phase. The combination treatment increased the expression of p-P38 of K562 cells compared with the cells exposed As2O3 alone. It is concluded that TPA can enhance the effect of As2O3 on inducing apoptosis and adjusting cell cycle , which will expect to provide a new therapeutic program.
authors.affiliation: Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University(Henan Province Cancer Hospital), Zhengzhou 450008, Henan Province, China.
authors.forename: Fang-Fang
authors.initials: FF
authors.lastname: Yuan
authors.affiliation: Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University(Henan Province Cancer Hospital), Zhengzhou 450008, Henan Province, China.
authors.forename: Xu-Hua
authors.initials: XH
authors.lastname: Zhang
authors.affiliation: Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University(Henan Province Cancer Hospital), Zhengzhou 450008, Henan Province, China.
authors.forename: Rui-Hua
authors.initials: RH
authors.lastname: Mi
authors.affiliation: Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University(Henan Province Cancer Hospital), Zhengzhou 450008, Henan Province, China.
authors.forename: Rui-Hua
authors.initials: RH
authors.lastname: Fan
authors.affiliation: Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Province Cancer Hospital), Zhengzhou 450008, Henan Province, China.
authors.forename: Qing-Song
authors.initials: QS
authors.lastname: Yin
authors.affiliation: Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University (Henan Province Cancer Hospital), Zhengzhou 450008, Henan Province, China. E-mail:weixudong63@126.com.
authors.forename: Xu-Dong
authors.initials: XD
authors.lastname: Wei
mesh_terms: D017209:Apoptosis / Q000187:drug effects*; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000494:pharmacology*; D002453:Cell Cycle / Q000187:drug effects*; D004357:Drug Synergism; D006801:Humans; D020014:K562 Cells; D010087:Oxides / Q000494:pharmacology*; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology*
chemical_list: D001152:Arsenicals; D010087:Oxides; D013755:Tetradecanoylphorbol Acetate; D000077237:Arsenic Trioxide